Rate My Professor Gina Ravenscroft

Ravenscroft's research centers on rare genetic diseases, particularly neurogenetic conditions in infants and children, encompassing congenital myopathies, neuropathies, fetal akinesia, and arthrogryposis. She has discovered more than 10 novel human disease genes, utilizing exome and genome sequencing, RNA sequencing, single-cell analyses, functional assays, and patient-derived iPSCs to investigate pathobiology, enhance diagnostics, and explore therapies. Notable publications as senior author include 'Neurogenetic fetal akinesia and arthrogryposis: genetics, expanding genotype-phenotypes and functional genomics' (Journal of Medical Genetics, 2020), 'Myoglobinopathy is an adult-onset autosomal dominant myopathy with characteristic inclusions' (Nature Communications, 2019), 'Bi-allelic mutations in MYL1 cause a severe congenital myopathy' (Human Molecular Genetics, 2018), 'Mutations in KLHL40 are a frequent cause of severe autosomal-recessive nemaline myopathy' (American Journal of Human Genetics, 2013), and 'Mouse models of dominant ACTA1 disease recapitulate human disease and provide insight into therapies' (Brain, 2011). She collaborates globally on gene discovery projects, contributes to diagnostic genomics, and holds roles such as Secretary of the National Association of Research Fellows and Chair of the Harry Perkins Institute's Early- and Mid-Career Researcher Committee. Ravenscroft advocates for women in science and mentors early-career researchers.